96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Methods and compositions for gene inactivation
#3602COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#3603LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS
#3604COMPARATIVE LIGAND MAPPING FROM MHC POSITIVE CELLS
#3605Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
#3606LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
#3607Methods of treating a disease or condition associated with abnormal angiogenesis
#3608MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN
#3609Peptides, compositions and uses thereof
#3610Ganglioside epitopes for treating Guillain-Barre syndrome
#3611Regulation of endogenous gene expression in cells using zinc finger proteins
#3612NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#3613Stabilized STAT3 decoy oligonucleotides and uses therefor
#3614Antibodies that bind polypeptides involved in the process of bone remodeling
#3615POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#3616REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN
#3617PEPTIDE PRODRUGS
#3618Diagnostic method for Alzheimer's disease
#3619HUMAN FERTILITY TEST USING DPY19L2
#3620Mutant Sodium Channel Nav1.7 and Methods Related Thereto
#3621Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
#3622Mycobacterial vaccines
#3623Chimeric receptors with 4-1BB stimulatory signaling domain
#3624Compositions and methods for determining genetic polymorphisms in the TMEM216 gene
#3625IL4/IL13 binding repeat proteins and uses
#3626Methods predicting risk of an adverse clinical outcome
#3627Mutated SUMO isoforms and uses thereof
#3628DIAGNOSIS MARKER, DIAGNOSIS METHOD AND THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS, AND ANIMAL MODEL AND CELL MODEL DEVELOPING AMYOTROPHIC LATERAL SCLEROSIS
#3629Production of glycoproteins with low N-glycolylneuraminic acid (NEU5GC) content
#3630Preparation of a Therapeutic Composition
#3631Bifunctional stapled polypeptides and uses thereof
#3632Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
#3633Methods for identifying candidate modulators of NOTUM activity
#3634COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CERVICAL CANCER
#3635WHEY PROTEIN CONCENTRATE, ITS PREPARATION AND ITS USE
#3636Albumin-Fused Anti-Angiogenesis Peptides
#3637Method and system of runtime analysis
#3638CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
#3639Mirac proteins
#3640INTERFERON-LIKE PROTEIN ZCYTO21
#3641Genetic products differentially expressed in tumors and the use thereof
#3642METHODS AND COMPOSITIONS FOR TREATMENT OF TUBEROUS SCLEROSIS COMPLEX
#3643Conjugates of biologically active polypeptides having an increased in vivo half-life
#3644MODULATION OF IMMUNE RESPONSE BY NON-PEPTIDE BINDING STRESS RESPONSE POLYPEPTIDES
#3645METHODS AND COMPOSITIONS FOR MODULATING APOPTOSIS
#3646Methods and compositions for the treatment of immune disorders
#3647Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood
#3648Compositions and methods for treatment of neuropathic pain
#3649Neuronal viability factor and use thereof
#3650INCORPORATION OF METHYL LYSINE INTO POLYPEPTIDES
#3651Isolated A-type FHF N-terminal domain peptides and methods of use
#3652Anticalins
#3653Multivalent heteromultimer scaffold design and constructs
#3654TUSC2 THERAPIES
#3655METHODS OF IMPROVING CARDIAC FUNCTION AND ATTENUATING AND/OR PREVENTING CARDIAC REMODELING WITH HSP20
#3656Compositions having antiangiogenic activity and uses thereof
#3657Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#3658Transducible polypeptides for modifying metabolism
#3659Anti-C5a binding antibodies with high block activity
#3660ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF
#3661Treatment of vasculoproliferative conditions with Lrg1 anatgonists
#3662BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY
#3663ORGANIC CATION TRANSPORTER POLYPEPTIDES
#3664Use of endostatin peptides for the treatment of fibrosis
#3665UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF
#3666PRODUCTION OF SECRETED BIOPRODUCTS FROM PHOTOSYNTHETIC MICROBES
#3667Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
#3668COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#3669Compositions and methods for inducing angiogenesis
#3670Polypeptides and nucleic acids for treating ErbB2-dependent cancers
#3671METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#3672Method of using heparin binding motif for treating asthma
#3673Vault complexes for cytokine delivery
#3674Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
#3675Compositions for improving migration potential of stem cells
#3676DRG11-responsive (dragon) polypeptides
#3677DRG11-responsive (DRAGON) gene family
#3678Methods of use of fragments of secreted frizzled related protein, sFRP
#3679CONTROLLED RELEASE FORMULATIONS OF LIPOCALIN MUTEINS
#3680EphA2 T cell epitopes and uses therefor
#3681DIAGNOSIS OF IN SITU AND INVASIVE BREAST CANCER
#3682MICROBUBBLE ASSISTED VIRAL DELIVERY
#3683METHODS FOR IDENTIFYING TARGETING DOMAINS AND METHOD AND COMPOSITIONS COMPRISING THE SAME
#3684Modified human plasma polypeptide or Fc scaffolds and their uses
#3685GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS
#3686METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE
#3687Glycan markers as measure of disease state of hepatic diseases
#3688ENHANCED PROTEIN TRANSDUCTION
#3689RAF DIMERS AND USES THEREOF
#3690POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#3691USE OF MULTIPLE RECOMBINATION SITES WITH UNIQUE SPECIFICITY IN COMBINATIONAL CLONING
#3692BIOMARKER COMPOSITION FOR DETECTING DIABETIC RETINOPATHY AND DIAGNOSTIC KIT THEREFOR
#3693HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS
#3694KIDNEY DISEASE TARGETS AND USES THEREOF
#3695Genetic vasectomy by overexpression of PRML-EGFP fusion protein in spermatids
#3696INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR-BINDING PROTEIN AND ITS NON-HUMAN TRANSGENIC MAMMALIAN ANIMALS
#3697Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#3698DRG11-responsive (DRAGON) gene family
#3699PEPTIDOMIMETIC MACROCYCLES
#3700Methods and compositions for treating and diagnosing diseases
#3701Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia
#3702Methods and compositions for specific modulation of MCL-1
#3703Method of detection using antibodies that specifically bind hedgehog-derived polypeptides
#3704Galectin-immunoglobulin chimeric molecules
#3705COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS
#3706Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research Reagents
#3707Radiofluorinated compounds and their preparation
#3708Method of predicting a behavior of one or more drugs
#3709Nucleic acids encoding TNFγ
#3710Mirac proteins
#3711Method for the treatment of pulmonary disease and method of producing proteins of use therein
#3712Human milk peptides
#3713Means for treating synucleinopathies
#3714Composition for inducing migration of neural stem cells containing periostin as effective ingredient
#3715Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies
#3716COMPOSITIONS AND MODULATION OF MYOCYTE ENHANCER FACTOR 2 (MEF2)
#3717Biomarker for psychiatric diseases including cognitive impairment and methods for detecting psychiatric diseases including cognitive impairment using the biomarkers
#3718Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#3719Biosynthetic Polypeptide Fusion Inhibitors
#3720Repeat protein from collection of repeat proteins comprising repeat modules
#3721Method of Genetically Altering and Producing Allergy Free Cats
#3722NOVEL BAK BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF
#3723Engineered cleavage half-domains
#3724GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF
#3725Quantitative Aggregation Sensors
#3726Vault compositions for immunization against Chlamydia genital infection
#3727CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING
#3728UNC-45A splice variants based cancer diagnostics and therapeutics
#3729METHOD OF ENHANCING AN IMMUNE RESPONSE
#3730Methods and compositions for targeting polyubiquitin
#3731Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#3732Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function
#3733Application and uses of PRG4 and therapeutic modulation thereof
#3734Stable analogs of peptide and polypeptide therapeutics
#3735Peptide ligands for G-protein coupled receptors
#3736SYSTEMIC CARNITINE DEFICIENCY GENE AND USES THEREOF
#3737Methods for modulating embryonic stem cell differentiation
#3738IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#3739Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects
#3740COMPOSITIONS AND METHODS USING ALPHA BETA-CRYSTALLIN IN PROTECTING THE MYOCARDIUM FROM ISCHEMIA/REPERFUSION INJURY
#3741Modified TGF-β superfamily protein
#3742186 Human Secreted Proteins
#3743Method of arraying ferritin
#3744RECOMBINANT PROTEIN OF FIBROBLAST GROWTH FACTOR HAVING ADHESIVE ACTIVITY FOR STEM CELLS AND METHOD FOR CULTURING STEM CELLS USING THE SAME
#3745Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer
#3746Proteins
#3747FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
#3748Method of arraying ferritin
#3749PEPTIDOMIMETIC MACROCYCLES
#3750SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same
#3751Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2
#3752Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells
#3753CANCER DIAGNOSIS METHOD USING THE GLYCOSYLATION OF A GLYCOPROTEIN
#3754Antibodies And Epitopes Specific To Misfolded Prion Protein
#3755Transducible delivery of nucleic acids using modified dsRNA binding domains
#3756COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY
#3757CHO/CERT cell lines
#3758METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
#3759Ang-2 Binding Complexes and Uses Thereof
#3760Nucleotide and amino acid sequences relating to respiratory diseases and obesity
#3761Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same
#3762MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS
#3763NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#3764Method for producing protein
#3765Molecular Interactions in Hematopoietic Cells
#3766Antimicrobial peptides based on CMAP27
#3767Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof
#3768Prostatitis-associated antigens and methods of use thereof
#3769Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist
#3770PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA
#3771CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING
#3772VEGF antagonist formulations for intravitreal administration
#3773SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
#3774NOVEL CAVIIDAE ALLERGENS AND USES THEREOF
#3775Human anti-tau antibodies
#3776COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#3777PARKIN SUBSTRATE AND ASSAY
#3778DIAGNOSIS AND TREATMENT OF CELL PROLIFERATION AND DIFFERENTIATION DISORDERS BASED ON THE FMN2 GENE
#3779Recombinantly produced allergens
#3780NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 121P1F1 USEFUL IN TREATMENT AND DETECTION OF CANCER
#3781MITOCHONDRIAL LOCALIZATION OF MUC1
#3782DOMINANT NEGATIVE MUTANTS OF SAM68 FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA)
#3783Sulfation of Wnt pathway proteins
#3784HNRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis
#3785DBC1, A NOVEL NATIVE INHIBITOR OF THE ANTI-AGING PROTEIN SIRT1
#3786Screening methods for transfusion related acute lung injury
#3787Lafora's disease gene
#3788Antibodies that bind stresscopin peptides
#3789Isoform Nell-1 peptide
#3790GQ protein competitive inhibitory polypeptides, preparation methods and uses thereof
#3791Methods and compositions for the treatment of cancer or other diseases
#3792B7-H1 antibodies and method of use
#3793ZCYTOR19 POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE
#3794NOVEL GENES, COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CERVICAL CANCER
#3795Compounds and methods useful for detection and treatment of cancer
#3796Method for secretory production of glycoprotein having human-type sugar chain using plant cell
#3797Caveolin 1-reporter protein knock-in mouse
#3798Synthetic peptides and peptide mimetics
#3799ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1
#3800Isolated genomic polynucleotide fragments from the p15 region of isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 4 (TSSC4)
#3801Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
#3802Manufacture of inter-alpha-inhibitor (IaIp) from plasma
#3803Combinatorial DNA library for producing modified -glycans in lower eukaryotes
#3804Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#3805Chlamydomonas intraflagellar transport 88 (IFT-88)
#3806PEPTIDE NETWORKS
#3807NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES
#3808gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
#3809Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
#3810UCP4
#3811Methods of preventing or treating brain diseases
#3812MOLECULES ABLE TO MODULATE THE EXPRESSION OF AT LEAST A GENE INVOLVED IN DEGRADATIVE PATHWAYS AND USES THEREOF
#3813DIABETES DIAGNOSTIC, PROPHYLACTIC, AND THERAPEUTIC COMPOSITIONS AND METHODS
#3814MIF antagonists
#3815RSPONDIN-3 INHIBITION IN BONE DISORDERS
#3816Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fusion
#3817E1-MINUS ADENOVIRUSES AND USE THEREOF
#3818Compounds and Methods for Modulating an Immune Response
#3819INTERFERON-LIKE PROTEIN ZCYTO21
#3820COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#3821Akt activity specifically inhibiting polypeptide
#3822Akt Nucleic Acids, Polypeptides, and Uses Thereof
#3823COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS
#3824Methods and compositions comprising tau oligomers
#3825INTEGRASE COFACTOR
#3826Removing polypeptides from stool
#3827Bone marrow targeting peptides
#3828Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
#3829GENES AND POLYPEPTIDES RELATING TO HUMAN PANCREATIC CANCERS
#3830Prion-specific peptoid reagents
#3831Antibody to SOST peptides
#3832PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis
#3833Cancer antigen eEF2
#3834DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3
#3835ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS
#3836Pancreatic cancer genes
#3837COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#3838Compositions and methods for treating kidney disease
#3839Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26)
#3840POT1 alternative splicing variants
#3841Polypeptides for Specific Targeting to Otx2 Target Cells
#3842Isolated GDF trap polypeptide
#3843Metastin derivatives and use thereof
#3844EXPANSION OF NK CELLS AND THERAPEUTIC USES THEREOF
#3845Modified chaperonin 10
#3846Wise/Sost nucleic acid sequences and amino acid sequences
#3847Method for the diagnosis and prognosis of malignant diseases
#3848Antagonistic peptides for frizzled-1 and frizzled-2
#3849Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies
#3850Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
#3851Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 6 (TSSC6)
#3852Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human SMS3
#3853Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human achaete-scute homolog 2 (HASH2)
#3854Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer
#3855Monocyte-derived nucleic acids and related compositions and methods
#3856Pre-ligand assembly domain of the IL-17 receptor
#3857THERAPEUTIC AGENT COMPRISING VASOHIBIN
#3858Hsp9O-targeted anti-cancer chimeric peptide
#3859Novel composition and methods for the treatment of psoriasis
#3860YEAST ECTOPICALLY EXPRESSING ABNORMALLY PROCESSED PROTEINS AND USES THEREFOR
#3861Nucleic acid molecules encoding B7-DC variants
#3862VAULT AGENTS FOR CHRONIC KIDNEY DISEASE
#3863Compositions and methods for treatment of neurodegenerative diseases
#3864Targets for treatment of hypercholesterolemia
#3865Sirtuin 6 activating peptides and cosmetic or pharmaceutical composition containing them
#3866Method for determination and quantification of radiation or genotoxin exposure
#3867TAU PROTEASE COMPOSITIONS AND METHODS
#3868Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
#3869WISP polypeptides and nucleic acids encoding same
#3870REGULATION OF PROTEIN LEVEL
#3871Antibodies that bind polypeptides involved in the process of bone remodeling
#3872POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
#3873METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN
#3874PROSAPOSIN AS A NEUROTROPHIC FACTOR
#3875PEPTIDE CAPABLE OF BINDING TO IMMUNOGLOBULIN
#3876DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, AND INTEGRIN ALPHA SUBUNIT PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREOF
#3877NANOPARTICLE FOR BIOAFFINITY ASSAYS
#3878Antibodies specific for sulfated sclerostin
#3879Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor
#3880Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
#3881COLON CANCER TARGETS AND USES THEREOF
#3882Mutant alpha-synuclein, and methods using same
#3883Insulin-like growth factor 1 receptor binding peptides
#3884Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy
#3885Use of the cathelicidin LL-37 and derivatives thereof for wound healing
#3886WDRPUH epitope peptides and vaccines containing the same
#3887POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#3888Bi-specific fusion proteins
#3889CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS
#3890Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#3891Method of protecting against heart failure
#3892PIMAP39 modulates LPS-induced inflammatory response
#3893Methods of identifying adipocyte specific genes, the genes identified, and their uses
#3894Identification of a novel BHD gene
#3895Method of producing a paralytic peptide
#3896Peptides and methods for inducing cell death
#3897NOVEL BAG PROTEINS AND NUCLEIC ACID MOLECULES ENCODING THEM
#3898POLYPEPTIDE MARKER FOR DIAGNOSIS OF ARTERIOSCLEROSIS, METHOD FOR DETECTION OF ARTERIOSCLEROSIS BY USING THE MAKER OR THE LIKE, AND KIT FOR DIAGNOSIS OF ARTERIOSCLEROSIS
#3899METHOD AND COMPOSITION FOR THE DIAGNOSIS AND MONITORING OF INFLAMMATORY DISEASES
#3900Tumor Antigen Protein, Gene, or Peptides from Topoisimerase 2 Alpha